Physical state changes of membrane lipids in human lung adenocarcinoma A(549) cells and their resistance to cisplatin
- PMID: 12127575
- DOI: 10.1016/s1357-2725(02)00056-0
Physical state changes of membrane lipids in human lung adenocarcinoma A(549) cells and their resistance to cisplatin
Abstract
The properties of membrane lipids in sensitive A(549) and resistant A(549)/DDP cells to cis-dichlorodiammine platinum[II] (cisplatin) were examined by combining different approaches. The results showed that fluorescence intensity (deltaF) of Merocyanine 540 (MC540) was 93.5 +/- 21.8 for the sensitive A(549) cells and 49.5 +/- 11.2 for the resistive A(549)/DDP cells, monitored by flow cytometry, which may indicate that membrane lipid packing of the sensitive A(549) cells were looser than that of the resistant A(549)/DDP cells. Diffusion rate of N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-1,2-hexadecanoyl-Sn-glycero-3-phosphatidyl-ethanolamine (NBD-PE) was slower in A(549)/DDP cells than in A(549) cells as detected by fluorescence recovery after photobleaching (FRAP) technique. Fatty acid analysis of the membrane lipids showed 21.6, 27.0 and 31.8% increase in the amount of C(18:1), C(18:2) and C(18:3) fatty acid, respectively, in A(549) cells as compared to A(549)/DDP cells. The total amount of unsaturated fatty acids in the plasma membrane lipid is 69.13% +/- 2.2% for A(549), and 55.08% +/- 1.8% for A(549)/DDP cells, respectively. The resistance to cisplatin in A(549)/DDP cells was confirmed by the measurements of the transmembrane influx of Rhodamine-123, cisplatin or Bodipy-cisplatin by fluorescence assay and inductively coupled plasma mass spectrometry (ICP-MS). From the results described previously, it is concluded that changes in the membrane lipids "composition" cause a change in the physical state of the plasma membrane lipids and that this may be associated with the resistance of A(549)/DDP cells to cisplatin.
Copyright 2002 Elsevier Science Ltd.
Similar articles
-
Alteration of membrane lipid biophysical properties and resistance of human lung adenocarcinoma A(549) cells to cisplatin.Sci China C Life Sci. 2001 Feb;44(1):25-32. doi: 10.1007/BF02882069. Sci China C Life Sci. 2001. PMID: 18763085
-
GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.PLoS One. 2017 Aug 3;12(8):e0182410. doi: 10.1371/journal.pone.0182410. eCollection 2017. PLoS One. 2017. PMID: 28771580 Free PMC article.
-
[Reverse effect of genetically modified adenovirus H101 on drug-resistance of A549/DDP cells to cisplatin].Ai Zheng. 2005 Aug;24(8):975-9. Ai Zheng. 2005. PMID: 16086876 Chinese.
-
Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.Cancer Chemother Pharmacol. 1999;44(3):193-202. doi: 10.1007/s002800050967. Cancer Chemother Pharmacol. 1999. PMID: 10453720
-
Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.Oncol Rep. 2015 Jan;33(1):372-82. doi: 10.3892/or.2014.3607. Epub 2014 Nov 13. Oncol Rep. 2015. PMID: 25394854
Cited by
-
Profiling single cancer cell metabolism via high-content SRS imaging with chemical sparsity.Sci Adv. 2023 Aug 18;9(33):eadg6061. doi: 10.1126/sciadv.adg6061. Epub 2023 Aug 16. Sci Adv. 2023. PMID: 37585522 Free PMC article.
-
Liposome leakage and increased cellular permeability induced by guanidine-based oligomers: effects of liposome composition on liposome leakage and human lung epithelial barrier permeability.RSC Adv. 2021 Sep 28;11(51):32000-32011. doi: 10.1039/d1ra05478c. eCollection 2021 Sep 27. RSC Adv. 2021. PMID: 35495488 Free PMC article.
-
Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity.Front Physiol. 2019 Jan 11;9:1898. doi: 10.3389/fphys.2018.01898. eCollection 2018. Front Physiol. 2019. PMID: 30687116 Free PMC article. Review.
-
On the relationship between drug's size, cell membrane mechanical properties and high levels of multi drug resistance: a comparison to published data.Eur Biophys J. 2009 Apr;38(4):537-46. doi: 10.1007/s00249-008-0385-x. Epub 2008 Dec 10. Eur Biophys J. 2009. PMID: 19066880
-
Sensitization of drug resistant sarcoma tumors by membrane modulation via short chain sphingolipid-containing nanoparticles.Nanoscale. 2020 Aug 28;12(32):16967-16979. doi: 10.1039/d0nr02257h. Epub 2020 Aug 11. Nanoscale. 2020. PMID: 32780078 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous